ADARx Pharmaceuticals, Inc. (NasdaqGS: ADRX)
Health Care · Biotechnology · US
$17.78
0.00% today · -8.1% 1Y
ADARx Pharmaceuticals, Inc. (NasdaqGS: ADRX) operates in the Biotechnology industry within the Health Care sector. The company is valued at $1.99B and employs 100 people.
Over the last twelve months the share price has lost 8.1%, trading between 16.64 and 23.21.
Tweenvest scores ADARx Pharmaceuticals, Inc. across four factors: quality 64/100, value 61/100. Its strongest factor is quality.
ADRX price history
Not enough price history to draw a chart yet.
Key figures
- Market cap
- $1.99B
- Revenue (TTM)
- $6.13M
- P/E
- —
- EPS
- -7.74
- Dividend yield
- —
- Beta (5Y)
- —
- 52-week high
- $23.21
- 52-week low
- $16.64
- Avg volume (3M)
- —
- Shares outstanding
- 112.06M
- Employees
- 100
- Next earnings
- —
About ADARx Pharmaceuticals, Inc.
ADARx Pharmaceuticals, Inc. is a late-clinical-stage biotechnology company. It focuses on developing next-generation small interfering RNA (siRNA) therapeutics for diseases with significant unmet medical needs. The company was founded by Zhen Li in December 2019 and is headquartered in San Diego, CA.
- ISIN
- US00654F1057
- Founded
- 2019
- Listed since
- Sep 25, 2026
- Exchange
- Nasdaq Global Select
- Currency
- USD
Other Biotechnology companies
| Company | Market cap | Price | Day |
|---|---|---|---|
| Wuhan Healthgen Biotechnology Corp.SHSE: 688765 | $2.02B | CN¥37.86 | -4.97% |
| Genus plcLSE: GNS | $2.02B | £22.72 | -0.35% |
| Palvella Therapeutics, Inc.NasdaqGM: PVLA | $2.00B | $132.89 | -4.24% |
| ABL Bio Inc.KOSDAQ: A298380 | $2.00B | ₩48,000.00 | -6.61% |
| OliX Pharmaceuticals, IncKOSDAQ: A226950 | $1.99B | ₩117,300.00 | +0.43% |
| Vir Biotechnology, Inc.NasdaqGS: VIR | $1.98B | $11.36 | -2.91% |
| Jinyu Bio-technology Co., Ltd.SHSE: 600201 | $1.93B | CN¥11.84 | +1.98% |
| Pell Bio-Med Technology Co., Ltd.TWSE: 6949 | $1.92B | NT$46.85 | +5.28% |
Figures last refreshed Oct 11, 2026.